Aims: The 2019 novel coronavirus disease (COVID-19) emerged in Wuhan, China, and was
characterized as a pandemic by the World Health Organization. Diabetes is an established …

Abstract Coronavirus disease 2019 (Covid-19) has affected millions of people and may
disproportionately affect those with hypertension and diabetes. Because of inadequate …

Abstract Purpose of Review In France, in order to describe the phenotypic characteristics of
patients with diabetes hospitalized for coronavirus disease-2019 (COVID-19) and to identify …

Background and aims To undertake a review and critical appraisal of published/preprint
reports that offer methods of determining the effects of hypertension, diabetes, stroke …

Background A high burden of severe disease and death from the coronavirus disease 2019
(COVID-19) has been consistently observed in older patients, especially those with pre …

Aims This study evaluated the impact of previous glycemic control and in-hospital use of
antidiabetic/antihypertensive drugs on the prognosis of COVID-19 patients with diabetes …

Purpose Infectious diseases are more frequent and can be associated with worse outcomes
in patients with diabetes. The aim of this study was to systematically review and conduct a …

Objective This study explores the clinical characteristics of patients with diabetes with severe
covid-19, and the association of diabetes with survival duration in patients with severe covid …

Background and aims To study the prevalence and impact of diabetes mellitus and other
comorbidities among hospitalized patients with COVID-19. Methods In a prospective …

ABSTRACT SARS-CoV-2 has caused a worldwide pandemic that began with an outbreak of
pneumonia cases in the Hubei province of China. Knowledge of those most at risk is integral …